The Selective Late Sodium Current Inhibitor Eleclazine, Unlike Amiodarone, Does Not Alter Defibrillation Threshold or Dominant Frequency of Ventricular Fibrillation-Reference-Cited by-同舟云学术

The Selective Late Sodium Current Inhibitor Eleclazine, Unlike Amiodarone, Does Not Alter Defibrillation Threshold or Dominant Frequency of Ventricular Fibrillation

Published:2017-03 Issue:3 Volume:69 Page:178-182
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Silva Ana F. G.,Bonatti Rodolfo,Batatinha Julio A. P.,Nearing Bruce D.,Zeng Dewan,Belardinelli Luiz,Verrier Richard L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference24 articles.

1. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias;Belardinelli;J Pharmacol Exp Ther.,2013

2. Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967;Sicouri;Heart Rhythm.,2013

3. Pathophysiology and pharmacology of the cardiac “late sodium current.”;Zaza;Pharmacol Ther.,2008

4. Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic stimulation;Justo;Heart Rhythm.,2016

5. Long-term outcome with the automatic implantable cardioverter-defibrillator;Winkle;J Am Coll Cardiol.,1989

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arrhythmogenic cardiac alternans in heart failure is suppressed by late sodium current blockade by ranolazine;Heart Rhythm;2019-02